Major Late-Breaking Trials from EuroPCR 2025

Spokesperson: T. Cuisset

Discussants: D. Capodanno, S. Windecker, D. Moliterno, G. Montalescot

Summary

Discover major late-breaking trials from EuroPCR 2025 in this session presenting pivotal study data. Highlights include meta-analyses from the PROTECTED TAVR and BHF PROTECT-TAVI studies, angiography versus physiology-guided PCI during TAVI (FAITAVI trial), and novel antiplatelet strategies following drug-coated stent implantation in acute coronary syndrome, with detailed clinical impact discussions.

Presentations available when logged in:

Meta-Analysis of individual patient data from the PROTECTED TAVR and BHF PROTECT-TAVI studies
Angiography versus physiology-guided PCI in patients undergoing TAVI: the functional assessment in TAVI (FAITAVI) trial
Study insights
Clinical impact
One-month DAPT followed by dose reduction of prasugrel after drug-coated stent insertion in Acute Coronary Syndrome
Study insights
Clinical impact

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Major Late-Breaking Trials from EuroPCR 2025

Log in or create account for free